SCHEMBL8287486

SCHEMBL8287486

CCN(CC)C(=O)c1cc2c(cn1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
CSF1R P07333 1/20 0.35
GSK3B P49841 3/20 0.35
CDK4 P11802 1/20 0.34
CCND1 P24385 1/20 0.34
CCND2 P30279 1/20 0.34
CCND3 P30281 1/20 0.34
POLB P06746 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
MEN1 O00255 1/20 0.34
PKM P14618 1/20 0.34
HPGD P15428 1/20 0.34
KMT2A Q03164 1/20 0.34
MAT2A P31153 2/20 0.34
PDE11A Q9HCR9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287920 0.87 CSF1R (0.37) LMNAMAPTCSF1RGSK3BCDK4
SCHEMBL8285291 0.86 GABRA1 (0.40) LMNAALDH1A1MAPTCSF1RGSK3B
SCHEMBL8286468 0.85 GSK3B (0.38) LMNAALDH1A1MAPTCSF1RGSK3B
SCHEMBL8287201 0.85 GSK3B (0.34) TSHRALDH1A1MAPTCSF1RGSK3B
SCHEMBL8287593 0.85 GSK3B (0.37) TSHRALDH1A1MAPTGSK3BCDK4
SCHEMBL8287205 0.84 GSK3B (0.37) CSF1RGSK3BCDK4CCND1CCND2
SCHEMBL8287930 0.84 CSF1R (0.47) LMNAALDH1A1MAPTCSF1RMEN1
SCHEMBL8362924 0.82 GSK3B (0.39) ALDH1A1MAPTCSF1RGSK3BCDK4
SCHEMBL8286472 0.82 EGFR (0.46) ALDH1A1MAPTPOLBRAB9AKMT2A
SCHEMBL8287526 0.82 MAPK13 (0.38) MAPTGSK3BCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed